SEARCH Study: SMS and Automated Phone Reminders for HPV Vaccination in Uganda: Randomized Controlled Trial
Sabrina B Kitaka1, Joseph Rujumba1, Sarah K Zalwango2,3
1Department of Pediatrics and Child Health, School of Medicine, College of Health Sciences, Makerere University, Kampala, UG.
Background:
Cervical cancer is currently the leading female cancer in Uganda. Most women are diagnosed with late-stage disease. Human papillomavirus (HPV) vaccination is the single most important primary preventive measure. While research regarding text message vaccine reminder use is strong in the U.S., their use has not yet been demonstrated in a pre-teen and adolescent population in Sub-Saharan Africa or other low- and middle-income countries.
Objective:
The objective of this pilot randomized controlled trial was to assess the impact of vaccine reminders with embedded interactive educational information on timeliness of HPV vaccination in Kampala, Uganda.
Methods:
In this randomized-controlled trial conducted in 2022, caregivers of adolescents needing a first or second HPV vaccine dose were recruited from an adolescent clinic and three community health centres in Kampala, Uganda. Families (n=154) were randomized 1:1 into intervention vs. usual care, stratified by dose (initiation, completion), language (English, Luganda) within each site. Intervention caregivers received a series of automated, personalized text messages or automated phone calls, based on family preference. Five messages were sent before the due date including both static and interactive educational information with five follow-up messages for those unvaccinated. Receipt of needed dose by 24 weeks post-enrolment was assessed by chi square, regression and Kaplan-Meier with log rank test. All analyses were intention-to-treat.
Results:
Overall, 154 caregivers enrolled (51.3% dose 1; 48.7% dose 2), and 64.3% spoke Luganda. Among the intervention arm, 62% requested text message and 38% automated phone reminders. There was no significant difference in requested mode by HPV vaccine dose or language. Intervention adolescents were more likely to receive a needed dose by 24 weeks (65.4% vs. 37.7%; p<0.001; RR 1.7 95% CI 1.2-2.4). There was no interaction by dose or language. There was no difference in vaccination by those requesting text message vs. phone reminders (65.3% vs 63.3%, p=0.86). The number needed to message for one additional vaccination was 3.6 (95% CI 2.3-8.2). Kaplan-Meier curves demonstrated more timely vaccination in the intervention arm (p<0.001).
Conclusions:
In this novel trial, text message and automated phone reminders were effective in promoting more timely HPV vaccination in this population.
Clinicaltrial:
ClinicalTrials.gov Identifier: NCT05151367.
